Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000919574-25-005781·GordonMD Global Investments LP
Schedule 13G ownership disclosure
PYXIS ONCOLOGY INC
Common Stock, par value $0.001 per share · CUSIP: 747324101
Event date: 2025-07-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- GordonMD Global Investments LP
Shares: 3,834,740.00 · Class: 6.2%
- GordonMD Long Biased Master Fund LP
Shares: 3,834,740.00 · Class: 6.2%
- GordonMD Long Biased GP LLC
Shares: 3,834,740.00 · Class: 6.2%
- Craig D. Gordon
Shares: 3,834,740.00 · Class: 6.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-005781
- Form type
- SCHEDULE 13G
- Filer
- GordonMD Global Investments LP
- CIK
- CIK 2039349
- Filed
- Sep 23, 2025
- Reporting period
- Jul 14, 2025
- Description
- Schedule 13G beneficial ownership